Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Central motor pathways in children with multiple sclerosis].
The Sphingosine 1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Post-Infarction Left Ventricular Remodeling in a Porcine Model of Ischemia-Reperfusion.
Multiple sclerosis and pregnancy: maternal considerations.
Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Substance Name: MEDI 551
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Change and processes of change within interventions to promote adjustment to multiple sclerosis: Learning from patient experiences.
Lobular panniculitis and lipoatrophy of the thighs with interferon-ß1a for intramuscular injection in a patient with multiple sclerosis.
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonb therapy in multiple sclerosis.
Balance control in multiple sclerosis: Correlations of trunk sway during stance and gait tests with disease severity.
[Gluten-related disorders and demyelinating diseases.]
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Biogen Idec to acquire full rights and control of Tysabri from Elan for upfront cash and contingent payments
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
[Recurring neuromyelitis without optic neuritis: a case report].
A RARE CASE OF ODONTOGENIC PARAINFECTIOUS INTRAORBITAL OPTIC NEURITIS WITH THE ABSENCE OF CLINICAL MANIFESTATION OF ORBITAL CELLULITIS.
[Neuromyelitis optica.]
Generation of oligodendroglial cells by direct lineage conversion.
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Pages
« first
‹ previous
…
207
208
209
210
211
212
213
214
215
…
next ›
last »